These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 196175)

  • 1. Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding.
    Nahorski SR
    Mol Pharmacol; 1977 Jul; 13(4):679-89. PubMed ID: 196175
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chronic reserpine administration on beta adrenergic receptors, adenylate cyclase and phosphodiesterase of the rat submandibular gland.
    Bylund DB; Forte LR; Morgan DW; Martinez JR
    J Pharmacol Exp Ther; 1981 Jul; 218(1):134-41. PubMed ID: 6113277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and altered sensitivity of cerebral beta-adrenoceptors assessed by [3H]-propranolol binding [proceedings].
    Nahorski SR; Smith BM
    Br J Pharmacol; 1976 Nov; 58(3):435P-436P. PubMed ID: 186146
    [No Abstract]   [Full Text] [Related]  

  • 4. Subsensitivity of the beta-adrenergic receptor-linked adenylate cyclase system of rat pineal gland following repeated treatment with desmethylimipramine and nialamide.
    Moyer JA; Greenberg LH; Frazer A; Weiss B
    Mol Pharmacol; 1981 Mar; 19(2):187-93. PubMed ID: 6262613
    [No Abstract]   [Full Text] [Related]  

  • 5. Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.
    Dolphin A; Adrien J; Hamon M; Bockaert J
    Mol Pharmacol; 1979 Jan; 15(1):1-15. PubMed ID: 218089
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex.
    Harden TK; Wolfe BB; Sporn JR; Poulos BK; Molinoff PB
    J Pharmacol Exp Ther; 1977 Oct; 203(1):132-43. PubMed ID: 198523
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of chick cerebral beta-adrenoceptors assessed by cyclic adenosine 3',5' monophosphate formation and [3H]-propranolol binding.
    Nahorski SR; Smith BM
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):23-8. PubMed ID: 18684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halothane effect on beta-adrenergic receptors in canine myocardium.
    Bernstein KJ; Gangat Y; Verosky M; Vulliemoz Y; Triner L
    Anesth Analg; 1981 Jun; 60(6):401-5. PubMed ID: 6263132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine-sensitive adenylate cyclase system in rat brain: role of adrenal corticosteroids.
    Mobley PL; Manier DH; Sulser F
    J Pharmacol Exp Ther; 1983 Jul; 226(1):71-7. PubMed ID: 6306226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive treatment: rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down regulation of beta-adrenergic receptors.
    Gillespie DD; Manier DH; Sulser F
    Commun Psychopharmacol; 1979; 3(3):191-5. PubMed ID: 227643
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone-sensitive adenylate cyclase. Mutant phenotype with normally regulated beta-adrenergic receptors uncoupled with catalytic adenylate cyclase.
    Bourne HR; Kaslow D; Kaslow HR; Salomon MR; Licko V
    Mol Pharmacol; 1981 Sep; 20(2):435-41. PubMed ID: 6272096
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain.
    Hegstrand LR; Minneman KP; Molinoff PB
    J Pharmacol Exp Ther; 1979 Aug; 210(2):215-21. PubMed ID: 222893
    [No Abstract]   [Full Text] [Related]  

  • 13. (3H)-Propranolol binding sites in myocardial membranes: nonidentity with beta adrenergic receptors.
    Vatner DE; Lefkowitz RJ
    Mol Pharmacol; 1974 May; 10(3):450-6. PubMed ID: 4847937
    [No Abstract]   [Full Text] [Related]  

  • 14. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamine-induced desensitization in turkey erythrocytes: cAMP mediated impairment of high affinity agonist binding without alteration in receptor number.
    Stadel JM; De Lean A; Mullikin-Kilpatrick D; Sawyer DD; Lefkowitz RJ
    J Cyclic Nucleotide Res; 1981; 7(1):37-47. PubMed ID: 6265513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of biogenic amines on the formation of adenosine 3', 5'-monophosphate in human thyroid slices.
    Sato A; Hashizume K; Onaya T; Miyakawa M; Makiuchi M
    Endocrinol Jpn; 1976 Aug; 23(4):319-25. PubMed ID: 191246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic receptor regulation of a cyclic AMP phosphodiesterase in C6 glioma cells.
    Schwartz JP; Onali P
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():195-203. PubMed ID: 6326524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adenosine cyclic monophosphate level, adenyl cyclase activity, 3,5'-cyclic AMP phosphodiesterase and protein kinases in rat brain in experimental carbon monoxide poisoning].
    Sikorska M
    Neuropatol Pol; 1980; 18(2):203-17. PubMed ID: 6251408
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the adenosine cyclic 3',5'-monophosphate content of rat cerebral cortex: ontogenetic development of the responsiveness to catecholamines and adenosine.
    Perkins JP; Moore MM
    Mol Pharmacol; 1973 Nov; 9(6):774-82. PubMed ID: 4148655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.